Part of Eye & Ear CareAntibacterial Eye & Ear Drops
Moxifloxacin, ciprofloxacin, and tobramycin drops for ophthalmic and otic infections. All formulations listed are procured under PMBI with verified WHO-GMP standard compliance.
Formulation & Pricing Breakdown19 pricedView details
Antibacterial Eye & Ear Drops Formulations (21)
Find Nearby KendraCiprofloxacin Eye Drops 0.3% w/v
Ciprofloxacin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Gentamicin Eye Drops 0.3% w/v
Gentamicin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Ofloxacin Eye Drops 0.3% w/v
Ofloxacin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Tropicamide Eye Drops 1% W/V
Parasympatholytic Mydriatic and Cycloplegic agent on the WHO Model List of Essential Medicines. It competitively blocks muscarinic acetylcholine receptors in the eye, paralyzing the pupillary sphincter muscle (causing mydriasis / pupil dilation) and the ciliary muscle (causing cycloplegia / paralysis of accommodation). Indicated for diagnostic mydriasis and cycloplegic refraction, and for preventing posterior synechiae in acute anterior uveitis.
Sulphacetamide Eye Drop 10 % w/v
Sulphacetamide Eye Drop 10 % w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Acyclovir Eye Ointment 3% W/W
Acyclovir (3% w/w ophthalmic ointment) is a synthetic purine nucleoside analogue antiviral on the WHO Model List of Essential Medicines. It is selectively converted by viral thymidine kinase into acyclovir monophosphate, which is subsequently converted to triphosphate, competitively inhibiting herpes simplex DNA polymerase and halting viral replication. Indicated for the treatment of herpes simplex keratitis (dendritic corneal ulcers).
Chloramphenicol Eye Ointment 1%w/w
Chloramphenicol Eye Ointment 1%w/w is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Moxifloxacin Hydrochloride Eye Drops 0.5% w/v
Moxifloxacin Hydrochloride (0.5% w/v ophthalmic solution) is a fourth-generation fluoroquinolone broad-spectrum bactericidal eye drop on the WHO Model List of Essential Medicines. It simultaneously inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, demonstrating high corneal tissue penetration, low resistance rates, and exceptional potency against Streptococcus pneumoniae, Staphylococcus aureus (including MRSA), and Gram-negative ocular pathogens. Self-preserved formulation eliminates the need for epithelial-toxic preservatives like benzalkonium chloride. Indicated for bacterial conjunctivitis and peri-operative prophylaxis in intraocular surgeries.
Tobramycin Eye Drops 0.3%w/v
Tobramycin (0.3% w/v eye drops) is a water-soluble aminoglycoside bactericidal antibiotic. It binds to the 30S ribosomal subunit, disrupting protein synthesis. Exhibits potent bactericidal activity against Pseudomonas aeruginosa, Proteus, and staphylococci. Indicated for external bacterial infections of the eye and surrounding adnexa (blepharitis, conjunctivitis, keratitis).
Azithromycin Eye Drops 1% w/v
Azithromycin Eye Drops 1% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Betaxolol Eye Drops 0.5% w/v
Betaxolol Eye Drops 0.5% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Gatifloxacin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops
Gatifloxacin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Gentamicin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops
Gentamicin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Homatropine Hydrobromide Eye Drops 2% w/v
Parasympatholytic Mydriatic and Cycloplegic agent on the WHO Model List of Essential Medicines. It competitively blocks muscarinic acetylcholine receptors in the eye, paralyzing the pupillary sphincter muscle (causing mydriasis / pupil dilation) and the ciliary muscle (causing cycloplegia / paralysis of accommodation). Indicated for diagnostic mydriasis and cycloplegic refraction, and for preventing posterior synechiae in acute anterior uveitis.
Levofloxacin Eye Drops 0.5 % w/v
Levofloxacin Eye Drops 0.5 % w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Eye Drops
Moxifloxacin and Corticosteroid (Dexamethasone 0.1% or Prednisolone 1%) ophthalmic drops is a broad-spectrum anti-infective and potent anti-inflammatory combination. Moxifloxacin (0.5%), a 4th-generation fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV across Gram-positive, Gram-negative, and atypical pathogens, while the steroid suppresses ocular surgical trauma, anterior chamber inflammation, and corneal edema. Indicated for post-operative prevention and treatment of inflammation and infection following cataract, refractive, or vitreoretinal surgery.
Natamycin Ophthalmic Suspension 5% w/v
Natamycin (5% w/v ophthalmic suspension) is a tetraene polyene broad-spectrum fungicidal antibiotic on the WHO Model List of Essential Medicines. It is the premier drug of choice for fungal keratitis. It binds selectively to fungal cell membrane ergosterol, disrupting membrane permeability and causing lethal leakage of essential ions and macromolecules. Highly active against filamentous fungi (Fusarium, Aspergillus, Curvularia) and yeasts (Candida). Indicated for fungal blepharitis, conjunctivitis, and fungal keratitis.
Bacitracin 400 IU + Neomycin 3400 IU + Polymyxin B 5000 IU Opthalmic Ointment
Bacitracin 400 IU + Neomycin 3400 IU + Polymyxin B 5000 IU Opthalmic Ointment is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Sodium Hyaluronate Eye Drops 0.1% w/v
Demulcent Ocular Lubricant and Artificial Tear formulation on the WHO Model List of Essential Medicines. Forms a viscoelastic, transparent, bioadhesive lubricating polymer shield over the cornea and conjunctiva, stabilizing the pre-corneal tear film, mimicking mucin layer adherence, and protecting the ocular surface against desiccating environmental stress and shear forces during blinking. Indicated for temporary relief of burning, irritation, and discomfort due to dry eye syndrome (keratoconjunctivitis sicca), digital eye strain, wind, or sun exposure.
Ofloxacin 0.3% w/v + Dexamethasone 0.1% w/v + Benzalkonium Chloride (As Preservative) 0.005% w/v Eye Drops
Ofloxacin 0.3% w/v + Dexamethasone 0.1% w/v + Benzalkonium Chloride (As Preservative) 0.005% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Tobramycin 0.3% w/v + Fluoromethalone 0.1% w/v Opthalmic Solution
Tobramycin and Fluorometholone ophthalmic suspension is an antibacterial and surface-selective corticosteroid combination. Tobramycin (0.3%) provides bactericidal coverage against Gram-negative ocular bacilli including Pseudomonas aeruginosa, while fluorometholone (0.1%) delivers targeted corneal and conjunctival anti-inflammatory action with significantly lower intraocular pressure elevation than dexamethasone. Indicated for steroid-responsive inflammatory ocular conditions with secondary bacterial infection risk.
Statutory Medical Guidance
All products listed are official PMBI-procured generic drugs and surgical consumables. Schedule H formulations require a valid doctor's prescription for dispensing at Jan Aushadhi Kendras. Always consult a certified healthcare professional before starting or altering any pharmaceutical therapy.